News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AstraZeneca PLC (AZN) Forms Collaboration With Shenzhen University



3/31/2014 1:15:05 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

March 31, 2014 -- AstraZeneca will collaborate with Shenzhen University Health Science Center to discover new treatments for chronic kidney disease, focusing on kidney damage caused by diabetes. Scientists from the Nephrology and Urology Center of Shenzhen University will put their academic and clinical skills together with the drug discovery/research expertise of AstraZeneca’s Shanghai Innovation Center researchers. Terms of the relationship were not disclosed. More details....

Stock Symbol: (NYSE: AZN)

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES